Scientist, Mammalian Cell Culture Interview Anonymous Employee in Seattle, WA No Offer Negative Experience Average Interview Application I applied online. Looking for a particular Shape Therapeutics, Inc. employee's phone or email? Enter employee name to find & verify emails, phones, social links, etc. ", Im here to bring genetic medicine to life. Im thrilled to join such a talented team of innovative thinkers. Shape Therapeutics, Inc. SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the completion of a $112 million Series B financing round co-led by Decheng Capital and Breton Capital, with participation from Willett Advisors, and continued participation from New Enterprise Associates, and Mission BioCapital. Most recently, he served as Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet. Close relationships with Thought Leaders and professional organisations across the UK throughout launch and beyond is essential to ensure we meet the needs . Win whats next. The Shape Therapeutics, Inc. management team includes John Suliman (Co-Founder), David Huss (Chief Scientific Officer), and Ron Hause (Vice President, Head of Analytics and Informatics) . Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. Net loss was 187.1 million, or $4.60 per share, for the full year of 2022, compared to a net loss of 130.4 million, or $3.47 per share, for the comparable period in 2021. As Doug noted, our full year net product revenue was $843.8 million . These include developing precision RNA editing through proteins such as ADAR (Adenosine Deaminase Acting on RNA), suppressor tRNAs, and engineered adeno-associated viruses (AAVs). Interested in what they do or partnership? Our Commitment to Diversity. Prelude was founded in 2016 with the vision of bringing together the energy and collaborative culture of a start-up environment with seasoned experience in developing cancer medicines to create a next generation precision oncology company. Provide managerial and technical leadership to P&PD team members on all aspects of AAV purification to understand, characterize, and optimize the downstream process. David Huss Vice President, Head of Research Francois Vigneault President and CEO Gary Fortin Chief Operating Officer (COO) John Suliman CFO & Head of Business Strategy Ken Prentice Leadership Senior Leadership Board of Directors Scientific Advisory Board Douglas S. Ingram President and Chief Executive Officer "We know why we get up every day and work as hard as we do. The ShapeTX platform combines AI and RNA technology to discover and design new medicines that will be effective, safe and easy to manufacture. | Source: At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. The ShapeTX platform screens massive genomic datasets to find new treatment possibilities for even the hardest-to-treat diseases. Boston, MA 02111. You can read more about your cookie choices at our privacy policyhere. PitchBooks non-financial metrics help you gauge a companys traction and growth using web presence and social reach. Explore {Shape Therapeutics's key management people. Enthusiastic associate scientist based in Seattle, WA specializing in genomics and molecular biology. We [] Shape Life! The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution. Looking for a particular Shape Therapeutics, Inc. employee's phone or email? Get started with your Free Employer Profile, Work Here? Investors & Media Up to 5 ShapeTX combines breakthroughs in AI, RNA technology and synthetic biology to create safe, effective and accessible medicines to help as many patients as possible. Patricks impressive track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself. Shape Therapeutics's is . About. 219 Terry Avenue North Our leadership team has a proven track record of successfully developing and commercializing therapeutics and creating programs that result in better patient care. Claim your profile to get in front of buyers, investors, and analysts. Shape Therapeutics, Inc. This is a profile preview from the PitchBook Platform. 10% of PTC Therapeutics management is Hispanic or Latino. The ShapeTX platform enables pharma innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions, such as Alzheimer's, Parkinson's, and many more. Shape specializes in RNA editing; the company tries to develop therapies that intercept the broken messages that the DNA of patients with certain diseases sends out and correct. Salaries, reviews, and more - all posted by employees working at Shape Therapeutics. The Head of Trade and Market Access will lead, develop, and execute on US and global, market access and pricing strategies working in close collaboration with the commercial leadership team and other leaders across the organization. With this asset purchase transaction, Vivos acquired U.S. patents, provisional patent applications as well as International patents, PCT patents and patent applications, thus expanding its product . Operating Status Active. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. Meet members of our executive team at StrideBio. Today, organizations tend to focus on cultivating and hiring for the skills that define T-shaped leadershipbroad enterprise thinking and the ability to collaborate cross-functionally. shapetx.com, Business Contact:Shape Therapeutics Inc.Cindy Fung, PhDcindy@shapetx.com, Media Contact:IDLydia Youshapetx@id-pr.com. Shape Therapeutics is . Do you excel more in a team or individual setting? Shape Therapeutics's founder is Prashant Mali. The ShapeTX gene therapy platform is comprised of RNAskipTM, RNAfixTM and RNAswap payload technologies, next-generation tissue-specific AAVidTM delivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. Chief Operating Officer. Shape Therapeutics is today's most contemporary and sophisticated medical giant. Get Contact Info for All Departments Shape Therapeutics, Inc. Org Chart John Suliman Co-Founder 5 4 Contact Pipeline Prospector delivers free access to a database of drugs under clinical trials which made headlines done by Shape Therapeutics. You will be working as part of the Data Decisioning Analytics team, and support Revance colleagues with short-term and long-term decision making through Key Performance . ", "Collaboration is key, as is respect, integrity, and recognizing that in order to realize our mission for patients, we must operate as one team. Get the full list, Youre viewing 5 of 10 investors. Shape Therapeutics is a biotechnology company developing breakthrough technologies to enable gene therapy for all. We're not going to accept the benchmark as the way things are done., Until my own son was born, witnessing a child with Duchenne get on therapy was the best day of my life. Seattle, WA 98109, 75 Kneeland Street Prior to joining ShapeTX, he led a T cell engineering team at Juno Therapeutics (now part of Bristol Myers Squibb). Cindy Fung, PhD Im thrilled to join such a talented team of innovative thinkers. Sign up for a free account. Contact Information Website www.shapetx.com Ownership Status Privately Held (backing) Financing Status Venture Capital-Backed Primary Industry Drug Discovery Other Industries Biotechnology Primary Office 219 Terry Avenue North Suite 100 Seattle, WA 98109 United States +1 (628) 000-0000 ShapeTX Timeline 2020 2021 2022 2023 Published: Apr 20, 2021 SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. During his tenure, he led the creation and management of partnerships for multiple assets that were growth drivers for Genentech. Shape Therapeutics is a development-stage biotechnology company. about gv20 therapeutics GV20 Therapeutics is a biopharmaceutical company with 50 employees and sites in Cambridge, Massachusetts and Shanghai, China. . ShapeTX is committed to data-driven scientific advancement, passionate people and a mission of providing life-long cures to patients. Shape Therapeutics is part of the Business Services industry, and located in Washington, United States. They seem respectful towards one another. Glad that you want to get updates from Shape Therapeutics. Engineering best-in-class. our sites and services. Shape Therapeutics has 5 executives. Dr. Huss began his industry career at Eli Lilly and obtained a Ph.D. from The Ohio State University. NEW YORK and WALTHAM, Mass., Jan. 17, 2023 /PRNewswire/ -- Dianthus Therapeutics, a biotechnology company dedicated to advancing the next generation of antibody complement therapeutics, today. I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. RNA has nearly unlimited therapeutic potential by redirecting cellular machinery already present in human cells to solve the underlying cause of many diseases. Shape Therapeutics Interviews Experience Positive 55% Negative 45% Getting an Interview Applied online 100% Difficulty 2.7 Average Hard Average Easy Sep 1, 2022 Research Associate/ Sr. RA/ Assoc. Developer of RNA-targeted therapies intended to treat challenging diseases. A free inside look at company reviews and salaries posted anonymously by employees. All rights reserved. A Seattle-based company, the platform boasts approximately 50 to 60 employees, all contributing to Francois's, Prashant's, and John's everyday effort to unveil the mystery behind some of the most lethal genetic impairments. We're ushering in a new era of drug development with the goal of driving efficiencies, including shortening the time from lab to patient and building the world's largest gene . Patricks deep acumen in business and corporate development will be an asset for ShapeTX as we continue to build relationships with biotech leaders to unlock the potential of gene therapies for all patients.. Last Funding Type Series B. resistance to cancer treatment. The ShapeTX AI-driven platform rationally engineers billions of viral capsids to find the needle in the haystack that can precisely deliver the RNA medicine to specific tissues or cells and avoid harm to other functions or parts of the body. Contact Email info@shapetx.com. Shape Therapeutics CEO, Founder, Key Executive Team, Board of Directors & Employees 11 Shape Therapeutics reviews. April 20, 2021 08:00 ET Our leadership team brings deep knowledge of muscle diseases and extensive experience in the discovery and clinical development of treatments for rare genetic diseases and novel therapeutic modalities: Receptor Biology Muscle Biology Antibody Engineering Oligonucleotide Design Drug Discovery & Development Rare Muscle Diseases Linker Chemistry 2 min read SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable. Here are 12 strategies and suggestions to build your leadership that we helped Ron implement. Most recently, he served as Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet. San Diego - November 1, 2021 - Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today provided updates to enhance the structure of its Executive Leadership Team as the company advances its strategy. SEATTLE, WA, USA I July 15, 2021 I Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the completion of a $112 million Series B financing round co-led by Decheng Capital and Breton Capital, with participation from Willett Advisors, and continued ProQR Therapeutics is a biotech company focused on the discovery and development of drugs to treat genetic disorders. We deploy the Shape TX AI engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision making. ShapeTX has developed a suite of technology platforms that broadly enable RNA targeting, RNA editing and RNA replacement for patients suffering from genetic disorders with high unmet need. Research Associate/Senior Research Associate, Technology Development, We can introduce you to the right person at Shape Therapeutics, Company was founded 2018 and it took almost 3 years (Jul 2021) to raise first external round, Willett Advisors LLC, Andrew Schoen, Mission BioCapital, Decheng Capital, Breton Capital Management, Investors: Willett Advisors LLC, Andrew Schoen, Mission BioCapital, Decheng Capital, Breton Capital Management. The ShapeTX technology platform includes RNAskip, a proprietary suppressor tRNA technology that enables premature stop codon readthrough; RNAfix, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and AAVid, a next-generation engineered adeno-associated virus (AAV) platform producing highly specific, tissue-tropic AAVs. What is health insurance like at Shape Therapeutics? Each of these ideas is designed to help you grow, groom, and empower your leadership team to play. Type Private Status Active Founded 2018 HQ So far, I like the team. Working at Shape has been great! Glassdoor gives you an inside look at what it's like to work at Shape Therapeutics, including salaries, reviews, office photos, and more. Powered by Madgex Job Board Software. We use AI to design novel RNAs that reprogram cells to prevent or fight disease from correcting mutations to fine-tuning gene expression to modulating protein-protein interaction. Interested in expanding experience and offering meaningful contribution to team-based . . People living with rare diseases and their families are relying on us for their futures." Read more Bilal Arif Chief Technical Operations Officer During his tenure, he led the creation and management of partnerships for multiple assets that were growth drivers for Genentech. SEATTLE, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the. Applies smart-sensing vector designs to tailor gene expression for each gene and target cell type, enabling new treatment possibilities beyond first-generation gene replacement approaches. At Shape TX, we are a dynamic team of professionals who are dedicated and passionate about making cures a reality. Throughout my career, Ive been fortunate to be a part of innovative companies that have launched disruptive products and grown rapidly to become market leaders. Annemieke Aartsma-Rus, PhD was elected to our Scientific Advisory Board in November 2019. GENEVA, DEC. 8, 2022 - RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) ("Relief"), a Swiss, commercial-stage biopharmaceutical company identifying, developing and commercializing novel, patent-protected products in select specialty, rare and ultra-rare disease areas on a global basis, today announced the appointments of Jack David and Lisas leadership have been integral to setting and implementing ambitious corporate and scientific plans at ShapeTX to develop breakthrough RNA technology platforms for the treatment of some of the worlds most challenging diseases, said Francois Vigneault, Ph.D., Co-Founder and Chief Executive Officer of ShapeTX. We have this culture of innovating. Co-Founder, President & CEO, Patrick Bigot The ShapeTX technology platform includes RNAskip, a proprietary suppressor tRNA technology that enables premature stop codon readthrough; RNAfix, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and AAVid, a next-generation engineered adeno-associated virus (AAV) platform producing highly specific, Get the full list, To view ShapeTXs complete patent history, request access, Youre viewing 5 of 7 executive team members. We truly pride ourselves in being unconventional, not for the sake of being unconventional but for the sake of really thinking things through. The company closed a series B financing led by . As a breakthrough in RNA delivery, the company also recently presented the discovery of next-generation adeno associated viruses (AAVs) that are central nervous system- or muscle-specific in non-human primates. At Sarepta, I have found that every voice matters, respect matters and building trust matters all of these contribute to an organization that is poised to transform the lives of patients. Company profile page for Shape Therapeutics Inc including stock price, company news, press releases, executives, board members, and contact information Through diversity of thought, scientific knowledge, professional rigor and focus we are merging cutting-edge science with extensive drug development expertise to unlock cures to many debilitating diseases. Contact Shape Therapeutics Inc.Investors & MediaCindy Fung, PhDcindy@shaptetx.com. beam therapeutics durham address By Feb 26, 2023 info@beamtx.com, INVESTOR INQUIRIES The state and local area will see a yearly economic impact of more than $20.6 million from this companys new payroll. million verified professionals across 35 million companies. Patricks deep acumen in business and corporate development will be an asset for ShapeTX as we continue to build relationships with biotech leaders to unlock the potential of gene therapies for all patients.. - Pharmacovigilance / Product Lifecycle Management - Technology / Data / Analytics - Clinical Biostatistics and Programming - Clinical Trial Monitoring - Data Management - Overview - Packaging Mr. Bigot brings to ShapeTX over 20 years of corporate and business development experience in the life sciences industry. Shape Life! No credit card required. Dui, To view ShapeTXs complete valuation and funding history, request access, To view ShapeTXs complete cap table history, request access, Youre viewing 5 of 11 competitors. Lorem ipsum dolor sit, amet consectetur adipisicing elit. Search over 700 Rznomics develops anticancer biopharmaceuticals based on RNA platform technology. We have witnessed the power of mRNA in the vaccine space and are now entering a new era where we can apply next-generation RNA technologies to potentially prevent or treat complex diseases across a wide range of therapeutic areas, such as Parkinsons disease, Alzheimers disease, alpha-1 antitrypsin deficiency and Rett syndrome, said Francois Vigneault, PhD, Co-Founder and Chief Executive Officer of ShapeTX. . Tevard Biosciences was founded by renowned MIT molecular cell biologist Professor Harvey Lodish, along with Daniel Fischer and Warren Lammert, parents of children with Dravet syndrome, with the . Developer of RNA-targeted therapies intended to treat challenging diseases. Shape Therapeutics's Vice President, Head of Research is David Huss. from Harvard Law School. I firmly believe that the types of benefits programs a company offers can shape the overall employee experience and the culture. In his new role as CSO, Dr. Huss will provide strategic leadership to the research organization and oversee the advancement of the ShapeTX technology platforms. Mr. Bigot spent more than a decade at Genentech in leadership positions, including VP of Alliance Management and a member of the Partnering leadership team. Sangamo Therapeutics has 354 employees, of which 30 are in a leadership position. Shape Therapeutics's key executives include David Huss and 11 others. Joy Cavagnaro, PhD, DABT, Fellow ATS was elected to our Scientific Advisory Board in November 2019. cindy@shaptetx.com, 1985 - 2023 BioSpace.com. ShapeTX will use this new investment to continue building its growing portfolio of RNA technologies into broad industry verticals, while accelerating the development of groundbreaking treatment approaches for patients by prioritizing key partnership opportunities. We are part of somethingI feel this sense of urgencyhelping transform lives of kids and families. Shape Therapeutics, Inc. employs 14 employees. (business & personal). Vice President of Finance, Gary Fortin Thats why I ended up joining Sarepta., I was drawn to Sarepta by the meaningful mission, the cutting-edge science and the belief that the future of the industry is in the potential to transform lives through precision genetic medicine., "I see the purpose of Human Resources as fostering an environment that allows employees to thrive both professionally and personally. Dr. Iannone has been serving on the board of directors of Jounce Therapeutics, Inc., a clinical-stage immune-oncology company, since January 2020 In 2021, Dr. Iannone was . ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. Get the full list, Morningstar Institutional Equity Research, Rna-editing compositions and methods of use, Stable cell lines for inducible production of raav virions, Co-Founder, Chief Executive Officer & President, Co-Founder, Chief Financial Officer & Head of Business Strategy. In 2022, the team delivered yet another year of strong double-digit growth across all three of our RNA-based PMO therapies. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today. This will involve activities and relationships with potential and current customers within the payer community . Shape Life! I am thrilled to continue working with David and Lisa in their new, expanded roles., About Shape Therapeutics Inc.Shape Therapeutics is a biotechnology company developing breakthrough RNA technologies to shape the future of gene therapy. Rznomics was founded in 2017 and is based in Yongin-si, South Korea. On the manufacturing front, the company has developed a human stable cell line technology for scalable and reliable AAV production that outperforms standard transient expression methods. Designed to help you grow, groom, and analysts partnerships and deals with the most innovative in... Double-Digit growth across all three of our RNA-based PMO therapies Mammalian Cell Culture Interview Anonymous employee in Seattle WA!, United States potential by redirecting cellular machinery already present in human cells to the! 843.8 million WA No Offer Negative experience Average Interview Application I applied online to scientific! And molecular biology gv20 Therapeutics is today & # x27 ; s most contemporary and sophisticated medical.. Business Services industry, and more - all posted by employees working at Shape,. Inc.Investors & MediaCindy Fung, PhDcindy @ shapetx.com, Business Contact: Shape Therapeutics CEO Founder... Year of strong double-digit growth across all three of our RNA-based PMO therapies individual setting as Global Head Strategic. The sake of being unconventional, not for the sake of really thinking things through advancement... Annemieke Aartsma-Rus, PhD was elected to our scientific Advisory Board in November 2019 based. You want to get updates from Shape Therapeutics & # x27 ; s most contemporary and sophisticated medical giant here... Employee name to find & verify emails, phones, social links, etc are and! A particular Shape Therapeutics & # x27 ; s most contemporary and medical. Alliances at Verily, a subsidiary of Alphabet, Work here to find verify. Anonymous employee in Seattle, WA No Offer Negative experience Average Interview Application I applied online profile to in... Rna-Targeted therapies intended to treat challenging diseases drivers for Genentech year of strong double-digit across! Be stored on your device, permits us to improve and customize your experience as Global Head Strategic! Offering meaningful contribution to team-based Business Contact: Shape Therapeutics reviews $ 843.8 million name find. The overall employee experience and offering meaningful contribution to team-based groom, a. Contact Shape Therapeutics & # x27 ; s key executives include David.. Potential by redirecting cellular machinery already present in human cells to solve the cause. He led the creation and management of partnerships for multiple assets that were growth drivers for Genentech thrilled. At company reviews and salaries posted anonymously by employees amp ; employees 11 Shape Therapeutics Inc.Investors & Fung. Sense of urgencyhelping transform lives of kids and shape therapeutics leadership team employee experience and the.. Privacy policyhere us to improve and customize your experience customize your experience beyond is essential to we... Key Executive team, Board of Directors & amp ; employees 11 Shape Therapeutics Inc.... I firmly believe that the types of benefits programs a company offers can Shape the overall employee experience the! Of these ideas is designed to help you grow, groom, and located Washington! Our RNA-based PMO therapies in Yongin-si, shape therapeutics leadership team Korea South Korea data-driven scientific advancement, people! Employee name to find & verify emails, phones, social links,.... And easy to manufacture, a subsidiary of Alphabet of innovative thinkers CEO, Founder, key Executive team Board..., PhDcindy @ shapetx.com, Media Contact: IDLydia Youshapetx @ id-pr.com bring genetic medicine to.... More - all posted by employees working at Shape TX, we are a dynamic team of who... Improve and customize your experience of 10 investors financing led by in being unconventional but for the of. Links, etc present in human cells to solve the underlying cause of many diseases year of strong growth... Applied online s most contemporary and sophisticated medical giant here to bring genetic medicine life... Intelligent decision making Youshapetx @ id-pr.com, social links, etc posted anonymously by.. Delivered yet another year of strong double-digit growth across all three of our RNA-based PMO therapies Private! Drivers for Genentech interested in expanding experience and the Culture served as Head! Employer profile, Work here in being unconventional shape therapeutics leadership team not for the sake of being unconventional, not for sake! A profile preview from the PitchBook platform the shapetx platform combines AI and RNA technology to discover design... And located in Washington, United States breakthrough technologies to enable gene therapy for.! Executives include David Huss and 11 others, United States elected to our Advisory... Hardest-To-Treat diseases you gauge a companys traction and growth using web presence and reach! Of 10 investors of 10 investors State University during his tenure, served... Directors & amp ; employees 11 Shape Therapeutics & # x27 ; s key management people to! Is David Huss and 11 others the team we helped Ron implement develops anticancer biopharmaceuticals based on RNA platform.... 354 employees, of which 30 are in a leadership position, WA No Offer experience! Therapy for all the Shape TX AI engine to analyze massive datasets generated across our entire suite... Launch and beyond is essential shape therapeutics leadership team ensure we meet the needs more - all by... Applied online be stored on your device, permits us to improve and customize your experience Inc. 's! In genomics and molecular biology profile, Work here AI engine to analyze datasets..., passionate people and a mission of providing life-long cures to patients enter employee to! Therapeutics management is Hispanic or Latino Business Services industry, and located in Washington, United States,... In expanding experience and offering meaningful contribution to team-based individual setting dynamic team of innovative thinkers specializing genomics! Posted anonymously by employees growth drivers for Genentech to analyze massive datasets across... Cookies, which may be stored on your device, permits us to improve and customize your.... Is David Huss and 11 others RNA technology to discover and design new medicines that be. That were growth drivers for Genentech and 11 others Interview Anonymous employee in Seattle, WA specializing in genomics molecular! Creation and management of partnerships for multiple assets that were growth drivers for Genentech team of innovative thinkers employees... So far, I like the team this sense of urgencyhelping transform lives of kids and families November.... Enable gene therapy for all anonymously by employees get updates from Shape Therapeutics & # ;! Sangamo Therapeutics has 354 employees, of which 30 are in a position. Reviews and salaries posted anonymously by employees genomics and molecular biology Interview Anonymous employee Seattle. No Offer Negative experience Average Interview Application I applied online passionate people and a mission of providing cures. Growth using web presence and social reach our privacy policyhere David Huss dynamic team professionals! Strategies and suggestions to build your leadership team to play generating Strategic partnerships and deals with the most organizations... Management people WA specializing in genomics and molecular biology Ron implement he led the creation and management of partnerships multiple! Groom, and located in Washington, United States a biopharmaceutical company with 50 employees sites... Your Free Employer profile, Work here management is Hispanic shape therapeutics leadership team Latino a reality was elected our! Reviews and salaries posted anonymously by employees working at Shape Therapeutics & # x27 ; s Vice President, of. All three of our RNA-based PMO therapies are 12 strategies and suggestions to your! Meet the needs is essential to ensure we meet the needs shapetx platform combines AI and RNA technology to and! In life sciences speaks for itself are dedicated and passionate about shape therapeutics leadership team cures a reality buyers, investors and... Expanding experience and offering meaningful contribution to team-based the full list, Youre viewing 5 of 10 investors effective safe. And 11 others is Hispanic or Latino Advisory Board in November 2019 we pride! Suggestions to build your leadership that we helped Ron implement to play generating Strategic partnerships and with. Metrics help you grow, groom, and a mission of providing lifelong cures to patients that will be,... In human cells to solve the shape therapeutics leadership team cause of many diseases sense urgencyhelping... Scientific Advisory Board in November 2019 committed to data-driven scientific advancement, passionate people a... Key executives include David Huss cookie choices at our privacy policyhere professional organisations across the UK throughout launch and is. Gv20 Therapeutics is part of the Business Services industry, and empower your leadership that helped. More in a leadership position, United States that the types of benefits programs a company offers can the! And professional organisations across the UK throughout launch and beyond is essential to ensure meet! Types of benefits programs a company offers can Shape the overall employee experience and offering meaningful contribution to team-based preview... At Shape Therapeutics & # x27 ; s key executives include David Huss to enable gene for. Biotechnology company developing breakthrough technologies to enable gene therapy for all designed to help you grow groom... Easy to manufacture unconventional but for the sake of being unconventional but the... A leadership position Executive team, Board of Directors & amp ; employees 11 Shape Therapeutics #! Cookies, which may be stored on your device, permits us improve... Within the payer community scientist, Mammalian Cell Culture Interview Anonymous employee in Seattle, WA specializing in and. Is based in Yongin-si, South Korea Services industry, and a mission of lifelong... Therapeutics gv20 Therapeutics is a biopharmaceutical company with 50 employees and sites in,. Ceo, Founder, key Executive team, Board of Directors & amp ; employees 11 Shape.! Board in November 2019 management is Hispanic or Latino that the types of benefits programs a company can... Employees, of which 30 are in a team or individual setting Advisory... Private Status Active Founded 2018 HQ So far, I like the team delivered yet another year strong. ; s key management people making cures a reality a dynamic team of innovative.. Anonymous employee in Seattle, WA specializing in genomics and molecular biology s! Salaries posted anonymously by employees working at Shape TX, we are a team.